Roles of SET7/9 and LSD1 in the Pathogenesis of Arsenic-induced Hepatocyte Apoptosis

doi:10.14218/JCTH.2020.00185

Original Article

OPEN ACCESS

Download PDF

Roles of SET7/9 and LSD1 in the Pathogenesis of Arsenic-induced Hepatocyte Apoptosis

Bing Han^1,2,# ,
Yi Yang^1,2,# ,
Lei Tang^3,#,
Qin Yang^1,2 and
Rujia Xie^1,2,*

Journal of Clinical and Translational Hepatology 2021;9(3):364-372

doi: 10.14218/JCTH.2020.00185

Received: December 28, 2020

Revised: February 22, 2021

Accepted: March 11, 2021

Published online: April 16, 2021

Author information

Citation: Han B, Yang Y, Tang L, Yang Q, Xie R. Roles of SET7/9 and LSD1 in the Pathogenesis of Arsenic-induced Hepatocyte Apoptosis. J Clin Transl Hepatol. 2021;9(3):364-372. doi: 10.14218/JCTH.2020.00185.

Abstract

Background and Aims

Multiple regulatory mechanisms play an important role in arsenic-induced liver injury. To investigate whether histone H3 lysine 4 (H3K4) methyltransferase (SET7/9) and histone H3K4 demethyltransferase (LSD1/KDM1A) can regulate endoplasmic reticulum stress (ERS)-related apoptosis by modulating the changes of H3K4 methylations in liver cells treated with arsenic_.

Methods

Apoptosis, proliferation and cell cycles were quantified by flow cytometry and real-time cell analyzer. The expression of ERS- and epigenetic-related proteins was detected by Western blot analysis. The antisense SET7/9 expression vector and the overexpressed LSD1 plasmid were used for transient transfection of LO2 cells. The effects of NaAsO₂ on the methylation of H3 in the promoter regions of 78 kDa glucose-regulated protein, activating transcription factor 4 and C/EBP-homologous protein were evaluated by chromatin immunoprecipitation assay.

Results

The protein expression of LSD1 (1.25±0.08 vs. 1.77±0.08, p=0.02) was markedly decreased by treatment with 100 µM NaAsO₂, whereas the SET7/9 (0.68±0.05 vs. 1.10±0.13, p=0.002) expression level was notably increased, which resulted in increased H3K4me1/2 (0.93±0.64, 1.19±0.22 vs. 0.71±0.13, 0.84±0.13, p=0.03 and p=0.003). After silencing SET7/9 and overexpressing LSD1 by transfection, apoptosis rate (in percentage: 3.26±0.34 vs. 7.04±0.42, 4.80±0.32 vs. 7.52±0.38, p=0.004 and p=0.02) was significantly decreased and proliferation rate was notably increased, which is reversed after inhibiting LSD1 (in percentage: 9.31±0.40 vs. 7.52±0.38, p=0.03). Furthermore, the methylation levels of H3 in the promoter regions of GRP78 (20.80±2.40 vs. 11.75±2.47, 20.46±2.23 vs. 14.37±0.91, p=0.03 and p=0.01) and CHOP (48.67±4.04 vs. 16.67±7.02, 59.33±4.51 vs. 20.67±3.06, p=0.004 and p=0.001) were significantly increased in LO₂ cells exposed to 100 µM NaAsO₂ for 24 h.

Conclusions

Histone methyltransferase SET7/9 and histone demethyltransferase LSD1 jointly regulate the changes of H3K4me1/me2 levels in arsenic-induced apoptosis. NaAsO₂ induces apoptosis in LO2 cells by activating the ERS-mediated apoptotic signaling pathway, at least partially by enhancing the methylation of H3 on the promoter regions of ERS-associated genes, including GRP78 and CHOP.

Keywords

Arsenic, SET7/9, LSD1, H3K4me1/2, ER stress

Introduction

Arsenic is a non-metal element, widely distributed in soil, water, minerals and plants in nature; and long-term exposure to a high-arsenic environment can cause arsenic poisoning in the organism.^1–3 A large number of epidemiological investigations and animal experiments have shown that arsenic poisoning can cause liver damage, and even lead to cirrhosis and liver cancer, which has become the main cause of death in patients with arsenic poisoning.^4,5 Therefore, there is an urgent need to identify novel therapeutic targets and to develop effective strategies for liver damage therapy. At present, studies on the mechanism of liver injury caused by arsenic poisoning mainly focus on oxidative stress,⁶ influence on enzyme activity,⁷ DNA damage, DNA methylation,⁸ and apoptosis.^9,10 Observations of involvement of many various mechanisms indicate that arsenic-induced hepatocyte apoptosis is one of the core events.^11,12

Arsenic can upregulate the expression levels of Fas and Fas ligand (i.e. FasL) in liver cells, and increase the apoptosis of cells through the death receptor pathway, causing liver damage.^13,14 Some scholars have found that arsenic can increase the expression levels of Bax and p53 proteins and induce hepatocyte apoptosis through a mitochondrial pathway.^15,16 While the endoplasmic reticulum (ER) is physiologically responsible for the control of proper protein folding and function, many factors such as the unfolded protein response, ER overload response and others, can disturb ER function, leading to ER stress (ERS). Apoptosis induced by ERS is a newly-discovered apoptosis pathway following the death receptor pathway and the mitochondrial pathway.^17,18 Previous studies have also demonstrated ERS-mediated hepatocyte apoptosis in rats.¹⁹ Further study found the PRKR-like endoplasmic reticulum kinase (PERK) signaling pathway were activated in arsenic-mediated liver cells.²⁰

However, how the PERK signaling pathway is activated has not been deeply researched. In recent years, epigenetics has gradually become a research hotspot. Epigenetics is a branch of genetics that studies the heritable changes in gene expression without changes in nucleotide sequence. Some scholars have found that the expression levels of 78 kDa glucose-regulated protein (GRP78), histone 3 lysine 4 methyltransferase (SET7/9) and histone 3 lysine 4 (H3K4) me2 are significantly increased in the renal tissues of diabetic nephrotic mice,²¹ suggesting that epigenetic histone modification may be associated with ERS. SET/9 specifically monomethylates the fourth lysine of histone 3 (i.e. H3K4) in multiple modifiable sites of histones.^22,23 Studies have shown that sodium arsenite can upregulate the level of dimethyl and methyl modification of H3K4 by downregulating the expression level of LSD1, which can open or increase the transcription of some genes.²⁴ Lysine-specific histone demethylase 1 (LSD1, also known as KDM1A), is a member of the amine oxidase family and a member of the demethylase family. LSD1 serves as a demethylase that specifically removes dimethyl and methyl modifications of H3K4 in vitro.

Based on the above research background, this experiment was designed to investigate whether SET7/9 and LSD1/KDM1A can regulate ERS-related apoptosis by modulating the changes of H3K4 methylations in liver cells treated with arsenic_.

Methods

Cells and reagents

Human normal hepatocyte L02 cells were obtained from the Shanghai Cell Bank of Chinese Academy of Sciences (China) and sodium arsenite was obtained from Shandong Xiya Reagent Chemical Industry (China). Fetal bovine serum, Dulbecco’s modified Eagle’s medium (GIBCO, New York, NY, USA), antibodies against GRP78, C/EBP-homologous protein (CHOP), LSD1, H3 and H3K4me1 (Abcam, Cambridge, UK), antibodies against H3K4me2 (Active Motif, Carlsbad, CA, USA), GAPDH (Bioprimacy Biotechnology, Wuhan, China), secondary antibodies (Boster Biological Engineering, Wuhan, China), SET7/9-specific small interfering RNAs (siRNAs) were purchased from Shanghai Jima Gene (China), negative small hairpin (sh)RNA and LSD1 overexpressed plasmids were obtained from Shanghai Jima Gene. OG-L002, an effective and selective LSD1 inhibitor, was obtained from Selleck Chemicals Company (Houston, USA). The chromatin immunoprecipitation assay (ChIP) kit and Lipofectamine 2000 were procured from Thermo Fisher Scientific (Waltham, MA, USA). The cell cycle and apoptosis detection kit were purchased from Bormai Biotechnology (Beijing, China)

Real-time cellular analysis

Cell proliferation was monitored using an xCELLigence Real-Time Cell Analysis instrument (xCELLigence DP System; ACEA Biosciences, Inc., San Diego, CA, USA), which can continuously monitor live cell proliferation, morphology and viability with a label-free assay. A 100 µL aliquot of LO2 suspended droplets were added to an E-Plate, including 10,000 cells, which was placed at 37°C in a humidified incubator containing 5% CO₂ for 6–8 h. After L02 cells adhered to the plate, arsenic was added at 100 µM,²⁰ and we performed continuous monitoring of the cell growth and proliferation process for 36 to 48 h.

Western blot

Taking out each cell culture, and adding “protein lysis solution” and protease inhibitors at a ratio of 99:1, each cell suspension was collected into a 1.5 mL centrifuge tube after lysing on the ice for 10 m; then, the 1.5 mL centrifuge tubes were centrifuged at 4°C and 12,000 r/m for 20 m. After precipitating, collecting the supernatant, and transferring the proteins to PVDF membranes, non-specific binding was blocked with 5% non-fat dry milk in Tris-buffered saline with Tween-20, and the membranes were probed overnight at 4°C with primary antibodies against GRP78 (1:1,500), CHOP (1:1,500), GAPDH (1:1,000), H3 (1:1,000), H3K4me1 (1:1,000), and H3K4me2 (1:1,000). The bound antibodies were detected with horseradish peroxidase-conjugated secondary antibodies and visualized using enhanced chemiluminescence reagents. The signal intensity was measured using Bio-Rad imaging system (Hercules, CA, USA) and analyzed by Quantity One software (Bio-Rad).

Apoptosis assay

Cells were digested with 0.25% trypsin without ethylene diamine tetraacetic acid (commonly referred to as EDTA) and washed with phosphate-buffered saline (PBS) 2–3 times; then, suspension liquids were collected into 10 mL centrifuge tubes. After centrifugation at 1,500 r/m for 5 m, 500 μL of binding buffer was added into tubes and resuspended. Annexin V-FITC (5 µL) and propidium iodide staining solution (5 µL) were added for a 5–15 m incubation.

Cell cycle assay

After the supernatant of each group was discarded and washed with PBS for 2–3 times, the cells of each group were digested with trypsin, free of EDTA, and the cell suspension was collected. The supernatant was discarded after centrifugation at 2,000 r/m for 5 m, and then washed with PBS to repeat the above steps. After the supernatant of the centrifuged tube was discarded, 250 µL PBS was added for resuspending, and 750 µL precooled anhydrous ethanol was added to each group to make the final concentration of ethanol 75%; after resuspension, the cells were incubated overnight at 4°C. On the second day, the cell suspensions of each group were centrifuged at 2,000 r/m for 5 m, and the supernatant was discarded. Then, the supernatant was processed with PBS in the same way. After the supernatant was discarded, the mixture of 500 µL was configured for each group in the proportion of RNase: Propidium Iodide=1:9.

ChIP-qPCR

LO2 cells (1×10⁶) were seeded onto 10-cm diameter dishes and were mock-treated with PBS (0 µmol/L NaAsO₂) or 100 µmol/L NaAsO₂ for 24 h. After treatment, ChIP kit (purchased from Thermo Fisher Scientific) was used to perform a ChIP assay. According to the manufacturer’s instructions, LO2 cells were cross-linked with 16% formaldehyde, and 1× glycine was added to terminate the cross-linking. The cells were lysed with 2 µL cell nuclease (ChIP grade) lysis buffer and the lysates were ultrasound-crushed to a length of 150–1,000 bp. Immunoprecipitation was performed at 4°C for overnight using magnetic beads A/G and the following antibodies: rabbit IgG (1:10), anti-RNA polymerase II (1:10), anti-H3K4me1 (1:10), and anti-H3K4me2 (1:10). The immunoprecipitates were washed and eluted using magnetic scaffolding (purchased from Thermo Fisher Scientific). Immunoprecipitated DNA was recovered by reverse cross-linking, then purified and dissolved in distilled water. The corresponding sample without any antibody added served as input control. Objective DNA and input DNA were analyzed by reverse transcription-qPCR. The abundance of immunoprecipitated target DNA was expressed as the percentage of input chromatin DNA. The primer sequences of the target genes GRP78, activating transcription factor 4 (ATF4), and CHOP are listed in Table 1.

Table 1

DNA sequences of primers used for reverse transcription- and ChIP-quantitative PCR

Gene	Forward, 5′–3′	Reverse, 5′–3′
GRP78	GGGATGGAGGAAGGGAGAAC	GAGGCATTTCCGCTGGTAAC
ATF4	GGTGGGTTCCATGGTCAAAT	AACACATCCACCACTGC
CHOP	CACGACCTCAGCCTGTCAAG	ACTGGAGTGGTGTGGCAATG

Statistical analysis

SPSS 20.0 statistical software was used for analysis. Data were expressed as the mean±standard deviation. The one-way analysis of variance method was used for the multivariate comparison, and the least significant difference method was used as a post hoc test. A p-value of <0.05 was considered to indicate a statistically significant difference.

Results

Arsenic significantly upregulates ERS-related proteins and H3K4me1/me2 in L02 cells

Compared with control group, the levels of SET7/9,²⁰ CHOP and H3K4me1 were significantly increased (Fig. 1B and Fig. 2B), whereas the level of LSD1 was obviously decreased in the model group (Fig. 2D). Compared with the negative siRNA transfection group, the expression levels of GRP78, CHOP, and H3K4me1 in the SET7/9 siRNA transfection group (Fig. 1B and Fig. 2B) were significantly decreased.

Fig. 1 Effect of arsenic on H3K4 methylation in L02 hepatocytes.

Cells were exposed to arsenic at 100 µmol/L for 24 h. Proteins, prepared from whole cell extracts, were analyzed by western blotting. The activities of H3K4me1/me2 were determined with respective specific antibodies. (A) SET7/9 protein knock-down efficiency. H3K4me1 expression was measured in control, model and SET7/9 knock-down L02 cells. (B) Data shown are mean±standard deviation of three independent experiments, *p<0.05 vs. control group; #p<0.05 vs. negative transfection group. (C) LSD1 protein knock-down and overexpression efficiency. H3K4me1/me2 expression was measured in control, model and LSD1 knock-down and OG-L002 group of L02 cells. (D) Data shown are mean±standard deviation of three independent experiments, *p<0.05 vs. control group; #p<0.05 vs. negative transfection group.

Fig. 2 Effect of arsenic on ERS-related proteins in L02 hepatocytes.

Cells were exposed to arsenic at 100 µmol/L for 24 h. Proteins, prepared from whole cell extracts, were analyzed by western blotting. The activities of GRP78, CHOP, and LSD1 were determined with respective specific antibodies. (A) SET7/9 protein knock-down efficiency. CHOP expression was measured in control, model and SET7/9 knock-down in L02 cells. (B) Data shown are mean±standard deviation of three independent experiments, *p<0.05 vs. control group; #p<0.05 vs. negative transfection group. (C) LSD1 protein knock-down and overexpression efficiency. GRP78, CHOP, and LSD1 expression was measured in control, model and LSD1 knock-down and OG-L002 group of L02 cells. (D) Data shown are mean±standard deviation of three independent experiments, *p<0.05 vs. control group; #p<0.05 vs. negative transfection group.

Compared with the negative shRNA transfection group, the expression levels of GRP78, CHOP, H3K4me1, and H3K4me2 were significantly decreased in the LSD1 group (Fig. 1D and Fig. 2D); the expression levels of GRP78, CHOP, H3K4me1 and H3K4me2 were notably increased in the OG-L002 group (Fig. 1D and Fig. 2D).

SET7/9 and LSD1 induce changes in apoptosis and cell cycle in L02 hepatocytes treated with arsenic

Flow cytometry showed that the apoptosis rate and the proportion of G1 phase cells were significantly increased in the model group compared with the control group. Compared with the negative transfection group, the apoptosis rate and the proportion of G1 phase cells were notably decreased in the SET7/9 siRNA transfection group and the LSD1 overexpression group, while the apoptosis rate and the proportion of G1 phase cells were obviously increased in the OG-L002 group [Fig. 3A(f)]. These results indicate that arsenic could promote apoptosis and increase the proportion of G1 phase cells, and histone modifying enzyme of SET7/9 and LSD1 could regulate apoptosis and cycle in arsenic-induced L02 cells [Fig. 3B(b) and 3C(b)]. The apoptotic data on SET7/9 has been published.²⁰

Fig. 3 Effect of arsenic on apoptosis and cycles in L02 hepatocytes.

(A) The changes of apoptosis in the LO2 cells of different groups were analyzed by flow cytometry. LSD1 protein knock-down and overexpression efficiency. Apoptosis was measured in control, model and LSD1 knock-down and OG-L002 group of L02 cells. (a: control; b: model; c: negative transfection; d: LSD1 overexpression group; e: OG L002; f: the apoptosis rate of different groups) Data shown are mean±standard deviation of three independent experiments, *p<0.05 vs. control group; #p<0.05 vs. negative transfection group. (B) The cell cycle distribution of each group. SET7/9 protein knock-down efficiency. Cell cycles were assessed in control, model and SET7/9 knock-down of L02 cells. (a: cycles diagram for each group; f: the cycles of different groups) Data shown are mean±standard deviation of three independent experiments, *p<0.05 vs. control group; #p<0.05 vs. negative transfection group. (C) The cell cycle distribution of each group. Cycles were assessed in control, model and LSD1 knock-down and OG-L002 group of L02 cells. (a: cycles diagram for each group; f: the cycles of different groups) Data shown are mean±standard deviation of three independent experiments, *p<0.05 vs. control group; #p<0.05 vs. negative transfection group.

SET7/9 and LSD1 mediate proliferation changes in arsenic-induced L02 hepatocytes

Real-time cellular analysis showed that the proliferation was significantly decreased in the model group compared with the control group. The proliferation rate was notably increased in the SET7/9 siRNA transfection group and in the LSD1 overexpression group compared with the negative transfection group, while the proliferation was obviously decreased in the OG-L002 group (Fig. 4B and 4D). These results illustrate that the histone modifying enzymes of SET7/9 and LSD1 could regulate proliferation in L02 cells.

Fig. 4 Effect of arsenic on growth in L02 hepatocytes.

(A) Real-time cellular analysis was employed to detect the SET7/9 protein knock-down efficiency. Proliferation was measured in control, model and SET7/9 knock-down of L02 cells. (B) The proliferation rate in control, model and SET7/9 knock-down. Data shown are mean±standard deviation of three independent experiments, *p<0.05 vs. control group; #p<0.05 vs. negative transfection group. (C) Real-time cellular analysis was employed to detect the LSD1 protein knock-down and overexpression efficiency. D: The proliferation rate was measured in control, model and LSD1 knock-down and overexpression LSD1 group. Data shown are mean±standard deviation of three independent experiments, *p<0.05 vs. control group; #p<0.05 vs. negative transfection group.

Arsenic treatment enhances the methylation level of histone H3 in the promoter regions of the GRP78 and CHOP genes in L02 hepatocytes

In order to confirm whether the regulation of transcription of GRP78, ATF4 and CHOP genes by arsenic is mediated by the upregulation of H3K4me1/me2, ChIP was performed. Following treatment with arsenic, the L02 cells were lysed and immunoprecipitated with specific anti-H3K4me1/me2 antibody. qPCR results demonstrated a significant increase in the H3K4me1/me2-associated promoter regions of the GRP78 and CHOP genes in L02 cells treated with 100 µM NaAsO₂ (Fig. 5A and 5C), while the promoter region of ATF4 did not show a significant increase in H3K4me1/me2 (Fig. 5B). These results confirmed that arsenic induces the expression of ERS-associated molecules by increasing their transcription, at least partially through enhancing the methylation of histone H3 in the promoter regions of these genes.

Fig. 5 Effect of H3K4me1 and H3K4me2 on GRP78, ATF4, and CHOP promoter activity in L02 hepatocytes.

(A) Changes in enrichment of H3K4me1 and H3K4me2 in the GRP78 promoter region. Data shown are mean±standard deviation of three independent experiments; *p<0.05 vs. control group, **p<0.01 vs. control group. (B) Changes of the enrichment of H3K4me1 and H3K4me2 in the ATF4 promoter region. Data shown are mean±standard deviation of three independent experiments; * p<0.05 vs. control group, **p<0.01 vs. control group. (C) Changes of the enrichment of H3K4me1 and H3K4me2 in the CHOP promoter region. Data shown are mean±standard deviation of three independent experiments; *p<0.05 vs. control group, **p<0.01 vs. control group.

Discussion

Arsenic can cause injury to many organs of the body,²⁵ among which liver injury has always been the focus.^26,27 In addition to endemic arsenic poisoning, medicine-induced arsenic poisoning also occurs.²⁸ Since ancient times, raw plants as well as refined plant products have been in common use, including as traditional Chinese medicine, Ayurveda in India, Kampo in Japan, traditional Korean medicine, and Unani in old Greece, all of which have well known associations with increased risk of liver damage.²⁹ In many countries, rice grains and complementary medicines are important sources of arsenic consumption.³⁰ Ayurvedic is an arsenic-containing compound, which is currently in use in India to control blood counts of patients with hematological malignancies.³¹ Long-term use of the Ayurvedic drug can also cause liver damage.³²

The Roussel Uclaf Causality Assessment Method (commonly known as RUCAM) is the best way to assess cause and effect in liver damage caused by arsenic poisoning from herbs and drugs. RUCAM, in its original version (published in 1993)³³ and its updated version (from 2016),³⁴ represents sophisticated diagnostic algorithms based on principles of artificial intelligence (commonly referred to as AI), as outlined in a recent editorial.³⁵

At present, a clinical study of arsenic detoxification in vivo is under way. The arsenic detoxification treatment with dimercaptopropanol and sodium dimercaptopropanesulfonate has not achieved the expected efficacy in patients. The antagonistic effect of selenium on arsenic, the antioxidant effect of superoxide dismutase on patients with arsenic poisoning and the protective effect on liver, lung, kidney, heart and other organs have been widely reported in treatment studies. Guizhou province reports of Chinese herbal medicine preparation for the treatment of chronic arsenic poisoning causing liver damage, such as Lu et al.³⁶ showing that whether by clinical manifestations or through the preparation before and after the organizational structure of the liver samples of vivisection, compound preparation of the Chinese herbal medicine HanDan diisopropylamine dichloroacetate liver damage caused by arsenic poisoning still produces obvious curative effect. Yun et al.³⁷ used ginkgo biloba leaves to treat 84 cases of chronic arsenic poisoning caused by coal burning, with anti-liver fibrosis intent. Serology and pathological histology observations indicated that the serum platelet activation factor (an important factor involved in liver injury and fibrosis) and four liver fibrosis indexes in the treatment group were significantly decreased (p<0.01), and the liver pathology was also improved to a certain extent in the treatment group, which was statistically significant when compared with the non-ginkgo biloba control group (p>0.01).

Our studies have shown that arsenic can regulate the changes of H3K4me1/me2 level by regulating histone methyltransferase SET7/9 and histone demethyltransferase LSD1 in the process of arsenic-induced hepatocyte apoptosis. Histone H3K4me1/me2 is involved in the activation of ERS-related proteins of GRP78 and CHOP during the process of arsenic-induced hepatocyte apoptosis. This provides a theoretical basis for further elucidating the pathogenesis of arsenic-induced liver injury.

Abbreviations

AI:: artificial intelligence

ATF4:: activating transcription factor 4

ChIP:: chromatin immunoprecipitation assay

CHOP:: C/EBP-homologous protein

EDTA:: ethylene diamine tetraacetic acid

ER:: endoplasmic reticulum

ERS:: endoplasmic reticulum stress

GRP78:: 78 kDa glucose-regulated protein

H3K4:: histone 3 lysine 4

LSD1/KDM1A:: histone 3 lysine 4 demethyltransferase

me:: methylation

PBS:: phosphate-buffered saline

PERK:: PRKR-like endoplasmic reticulum kinase

RTCA:: real-time cell analyzer

RUCAM:: Roussel Uclaf causality assessment method

SET7/9:: histone 3 lysine 4 methyltransferase

shRNA:: small hairpin

siRNA:: small interfering RNA

Declarations

Acknowledgement

We thank Leng Liang for technical advice in using flow cytometry and microscopy (Basic Medical Science Research Center of Guizhou Medical University). We would like to thank Liu Li for her comments on this manuscript.

Data sharing statement

All data are available upon request.

Funding

The present study was supported by the National Natural Science Foundation of China (Grant No. 81100284),Guizhou Science and Technology Cooperation Platform Personnel [2018] (Grant No. 5779-10,5779-19),and Science and Technology Foundation of Guizhou Province (Grant No. ZK [2021]-364)

Conflict of interest

The authors have no conflict of interests related to this publication.

Authors’ contributions

Study concept and design (BH), acquisition of data (YY, LT), analysis and interpretation of data (YY, LT), drafting of the manuscript (YY), critical revision of the manuscript for important intellectual content (BH), administrative, technical, or material support, study supervision (BH, QY, RX).

References

1	Kumar R, Mukherji MD, Chakraborty S, Mukherji R. A review on a heavy metal (arsenic) contamination in ground water, soil and translocation in plants. Indian Journal of Environmental Protection 2018;38(7):591-600

2	Adeyemi OS, Meyakno E, Akanji MA. Inhibition of Kupffer cell functions modulates arsenic intoxication in Wistar rats. Gen Physiol Biophys 2017;36(2):219-227 View Article

3	Abu El-Saad AM, Al-Kahtani MA, Abdel-Moneim AM. N-acetylcysteine and meso-2,3-dimercaptosuccinic acid alleviate oxidative stress and hepatic dysfunction induced by sodium arsenite in male rats. Drug Des Devel Ther 2016;10:3425-3434 View Article

4	Pompili M, Vichi M, Dinelli E, Erbuto D, Pycha R, Serafini G, et al. Arsenic: Association of regional concentrations in drinking water with suicide and natural causes of death in Italy. Psychiatry Res 2017;249:311-317 View Article

5	El-Bahnasawy MM, Mohammad Ael-H, Morsy TA. Arsenic pesticides and environmental pollution: exposure, poisoning, hazards and recommendations. J Egypt Soc Parasitol 2013;43(2):493-508 View Article

6	Li C, Li J, Zhang A, Yu C, Xu Y, Xiong X, et al. Intervention effects of curcumin on hepatic oxidative stress injury in water arsenic-exposed rats. Chinese Journal of Endemiology 2015;34(6):406-410 View Article

7	Bronkowska M, Łoźna K, Figurska-Ciura D, Styczyńska M, Orzeł D, Biernat J, et al. Influence of arsenic on selected biochemical blood parameters in rats fed diet with different fat and protein content. Rocz Panstw Zakl Hig 2015;66(3):233-237

8	Chen L, Zhang A, Yu C, Dong X, Huang X. Arsenic exposure causes human 8-hydroxyguanine DNA glycosidase 1 gene methylation and DNA oxidative damage. Chinese Journal of Pharmacology and Toxicology 2014;28(2):216-220 View Article

9	Santra A, Chowdhury A, Ghatak S, Biswas A, Dhali GK. Arsenic induces apoptosis in mouse liver is mitochondria dependent and is abrogated by N-acetylcysteine. Toxicol Appl Pharmacol 2007;220(2):146-155 View Article

10	Liu S, Li X, Tan C, Liu H, Wu B. Effects of ER stress and PUMA on 5-FU-induced liver cell injury and apoptosis. Journal of Sun Yat-sen University 2019;3:364-371 View Article

11	Yang DP, Li J, Huang XX, Zhang AH, Yun H, Xie ZJ. Apoptosis in arsenic poisoning hepatic injury caused by coal burning. Journal of Military Surgeon in Southwest China 2005;7(4):1-3 View Article

12	Xie TT, Zhang AH. Role of p53-mediated mitochondrial apoptotic pathway in arsenic liver injury caused by coal-burning. Chin J Pharmacol Toxicol 2014;28(2):210-215 View Article

Liu J, Zhao H, Wang Y, Shao Y, Li J, Xing M. Alterations of antioxidant indexes and inflammatory cytokine expression aggravated hepatocellular apoptosis through mitochondrial and death receptor-dependent pathways in Gallus gallus exposed to arsenic and copper. Environ Sci Pollut Res Int 2018;25(16):15462-15473 View Article

14	Zhao H, He Y, Li S, Sun X, Wang Y, Shao Y, et al. Subchronic arsenism-induced oxidative stress and inflammation contribute to apoptosis through mitochondrial and death receptor dependent pathways in chicken immune organs. Oncotarget 2017;8(25):40327-40344 View Article

15	Choudhury S, Ghosh S, Mukherjee S, Gupta P, Bhattacharya S, Adhikary A, et al. Pomegranate protects against arsenic-induced p53-dependent ROS-mediated inflammation and apoptosis in liver cells. J Nutr Biochem 2016;38:25-40 View Article

16	Wang C, Ning Z, Wan F, Huang R, Chao L, Kang Z, et al. Characterization of the cellular effects and mechanism of arsenic trioxide-induced hepatotoxicity in broiler chickens. Toxicol In Vitro 2019;61:104629 View Article

17	Zhang XQ, Xu CF, Yu CH, Chen WX, Li YM. Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol 2014;20(7):1768-1776 View Article

18	Rasheva VI, Domingos PM. Cellular responses to endoplasmic reticulum stress and apoptosis. Apoptosis 2009;14(8):996-1007 View Article

19	Xue QX, Shen X, Tian T, Han B, Xie RJ, He Y, et al. Metallothionein decreases the expression of GRP78 and CHOP proteins followed by apoptosis of liver cells in arsenic poisoning rats. Basic & Clinical Medicine 2015;35(6):739-743 View Article

20	Tang L, Xie RJ, Zheng L, Tian T, Yu L, Hu XX, et al. Effect of SET7/9-mediated endoplasmic reticulum stress on arsenic-induced hepatocyte apoptosis. Chinese Journal of pathophysiology 2019;35(02):186-189 View Article

21	Chen J, Guo Y, Zeng W, Huang L, Pang Q, Nie L, et al. ER stress triggers MCP-1 expression through SET7/9-induced histone methylation in the kidneys of db/db mice. Am J Physiol Renal Physiol 2014;306(8):F916-F925 View Article

22	Nishioka K, Chuikov S, Sarma K, Erdjument-Bromage H, Allis CD, Tempst P, et al. Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation. Genes Dev 2002;16(4):479-489 View Article

23	Tamura R, Doi S, Nakashima A, Sasaki K, Maeda K, Ueno T, et al. Inhibition of the H3K4 methyltransferase SET7/9 ameliorates peritoneal fibrosis. PLoS One 2018;13(5):e0196844 View Article

24	Li ZR, Wang S, Yang L, Yuan XH, Suo FZ, Yu B, et al. Experience-based discovery (EBD) of aryl hydrazines as new scaffolds for the development of LSD1/KDM1A inhibitors. Eur J Med Chem 2019;166:432-444 View Article

25	Pagrut N, Ganguly S, Tekam S, Pendharkar R, Kumar V. Histological alterations in arsenic induced various organs in rats. Journal of Entomology and Zoology Studies 2018;6(3):1428-1429

26	Bali İ, Bilir B, Emir S, Turan F, Yılmaz A, Gökkuş T, Aydın M. The effects of melatonin on liver functions in arsenic-induced liver damage. Ulus Cerrahi Derg 2016;32(4):233-237 View Article

27	Bambino K, Zhang C, Austin C, Amarasiriwardena C, Arora M, Chu J, et al. Inorganic arsenic causes fatty liver and interacts with ethanol to cause alcoholic liver disease in zebrafish. Dis Model Mech 2018;11(2):dmm031575 View Article

28	Wang LM. Chronic arsenic poisoning caused by long-term taken Niuhuang Ninggong tablet: a report of 2 cases. Zhongguo Zhong Xi Yi Jie He Za Zhi 2005;25(3):213

29	Quan NV, Dang Xuan T, Teschke R. Potential hepatotoxins found in herbal medicinal products: A systematic review. Int J Mol Sci 2020;21(14):5011 View Article

30	Sharma S, Kaur I, Nagpal AK. Assessment of arsenic content in soil, rice grains and groundwater and associated health risks in human population from Ropar wetland, India, and its vicinity. Environ Sci Pollut Res Int 2017;24(23):18836-18848 View Article

31	Treleaven J, Meller S, Farmer P, Birchall D, Goldman J, Piller G. Arsenic and ayurveda. Leuk Lymphoma 1993;10(4-5):343-345 View Article

32	Khandpur S, Malhotra AK, Bhatia V, Gupta S, Sharma VK, Mishra R, et al. Chronic arsenic toxicity from Ayurvedic medicines. Int J Dermatol 2008;47(6):618-621 View Article

33	Danan G, Benichou C. Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993;46(11):1323-1330 View Article

34	Danan G, Teschke R. RUCAM in drug and herb induced liver injury: The update. Int J Mol Sci 2015;17(1):14 View Article

35	Teschke R. DILI, HILI, RUCAM algorithm, and AI, the artificial intelligence: Provocative issues, progress, and proposals. Arch Gastroenterol Res 2020;1(1):4-11

36	Wu J, Lu T, Cheng ML. Therapeutic effects of the Chinese Medicine Han-Dan-Gan-Le, on arsenic-induced liver injury in Guizhou, China. Chinese Journal of Endemiology 2006;25(1):86-89 View Article

37	He Y, Zhang A, Yang D, Wang J, Wei X, Huang X. Clinical study on treatment to hepatic fibrosis of coal-brunt arsenic with ginkgo leaf. Journal of Military Surgeonin in Southwest China 2005;7(1):1-3 View Article

Copyright © 2021 Authors. This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 4.0 License (CC BY-NC 4.0), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.